41
TITLE: Spirooxadiazoline oxindoles with promising in vitro antitumor activities
AUTHORS: Carlos J A Ribeiro; Joana D Amaral; Cecilia M P Rodrigues ; Rui Moreira ; Maria M M Santos;
PUBLISHED: 2016, SOURCE: MEDCHEMCOMM, VOLUME: 7, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
42
TITLE: Novel squaramides with in vitro liver stage antiplasmodial activity  Full Text
AUTHORS: Carlos J A Ribeiro; Margarida Espadinha; Marta Machado; Jiri Gut; Lidia M Goncalves; Philip J Rosenthal; Miguel Prudencio ; Rui Moreira ; Maria M M Santos;
PUBLISHED: 2016, SOURCE: BIOORGANIC & MEDICINAL CHEMISTRY, VOLUME: 24, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
43
TITLE: Chemical Variations on the p53 Reactivation Theme  Full Text
AUTHORS: Carlos J A Ribeiro; Cecilia M P Rodrigues ; Rui Moreira ; Maria M M Santos;
PUBLISHED: 2016, SOURCE: PHARMACEUTICALS, VOLUME: 9, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 12
IN MY: ORCID
44
TITLE: Enantiopure Indolo[2,3-a]quinolizidines: Synthesis and Evaluation as NMDA Receptor Antagonists  Full Text
AUTHORS: Nuno A L Pereira; Francesc X Sureda; Maria Perez; Mercedes Amat; Maria M M Santos;
PUBLISHED: 2016, SOURCE: MOLECULES, VOLUME: 21, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
45
TITLE: Chemical Variations on the p53 Reactivation Theme  Full Text
AUTHORS: Carlos J A Ribeiro; Cecilia M P Rodrigues; Rui Moreira; Maria M M Santos;
PUBLISHED: 2016, SOURCE: PHARMACEUTICALS, VOLUME: 9, ISSUE: 2
INDEXED IN: WOS
49
TITLE: Indolo[2,3-a]quinolizidines and derivatives: Bioactivity and asymmetric synthesis
AUTHORS: Pérez, M; Espadinha, M; Santos, MMM;
PUBLISHED: 2015, SOURCE: Current Pharmaceutical Design, VOLUME: 21, ISSUE: 38
INDEXED IN: Scopus
IN MY: ORCID
50
TITLE: Designing covalent inhibitors: A medicinal chemistry challenge
AUTHORS: Lopes, F ; Santos, MMM; Moreira, R ;
PUBLISHED: 2015, SOURCE: Biomedical Chemistry: Current Trends and Developments
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 5 of 7. Total results: 67.